Characterization of the novel HLA-B*42:01:05 allele by two next-generation sequencing methods.

Alleles Genes, MHC Class I HLA-B Antigens / genetics High-Throughput Nucleotide Sequencing Humans
HLA-B*42:01:05 HLA NGS novel HLA allele

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
02 2022
Historique:
revised: 16 10 2021
received: 11 10 2021
accepted: 18 10 2021
pubmed: 23 10 2021
medline: 29 4 2022
entrez: 22 10 2021
Statut: ppublish

Résumé

The novel HLA-B*42:01:05 allele was characterized using two next generation sequencing technologies.

Identifiants

DOI: 10.1111/tan.14460 PMID: 34676687
pubmed: 34676687
doi: 10.1111/tan.14460
doi:

Substances chimiques

HLA-B Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-121

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020;48(D1):D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Orane Calvo De Olmos (O)

Histocompatibility and Immunogenetics Laboratory, Etablissement Français du Sang Centre-Pays de la Loire, Nantes, France.

Francoise Bonneville (F)

Histocompatibility and Immunogenetics Laboratory, Etablissement Français du Sang Centre-Pays de la Loire, Nantes, France.

Gaelle Blanchet (G)

Histocompatibility and Immunogenetics Laboratory, Etablissement Français du Sang Centre-Pays de la Loire, Nantes, France.

Alexandre Walencik (A)

Histocompatibility and Immunogenetics Laboratory, Etablissement Français du Sang Centre-Pays de la Loire, Nantes, France.
ORCID: 0000-0001-7748-2982

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Characterization of the novel HLA-B*42:01:05...
questionsmedicales.fr › Phénomènes du système immunitaire › Phénomènes immunogénétiques › Complexe majeur d'histocompatibilité › Gènes MHC de classe I › Characterization of the novel HLA-B*42:01:05...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-B › Characterization of the novel HLA-B*42:01:05...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Characterization of the novel HLA-B*42:01:05...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Characterization of the novel HLA-B*42:01:05...